4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037482
Chief Legal Officer sold 45,119 shares at an average $22.10 ($996,963)
- Chief Legal Officer acquired 33,189 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-01 | Option exercise | +33,189 | 176,807 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-01 | Sale | −9,746 | $22.72 | $221,448 | 167,061 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-01 | Sale | −5,254 | $23.57 | $123,851 | 161,807 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-02 | Sale | −12,483 | $21.50 | $268,412 | 149,324 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-02 | Sale | −2,517 | $22.32 | $56,173 | 146,807 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-02 | Sale | −12,732 | $21.51 | $273,822 | 134,075 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-02 | Sale | −2,387 | $22.31 | $53,257 | 131,688 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2021-06-01 | Option exercise · Restricted Stock Units | −33,189 | 0 | D | ||
| Open-market sales · 45,119 sh · avg $22.10 · $996,963 | |||||||
Loading xslF345X03/doc4.xml…